# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178879-25-000003
Filing Date
2025-02-19
Accepted
2025-02-19 16:02:51
Documents
103
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | fold-20241231.htm iXBRL | 10-K | 2109480
2 | EX-4.3 | fold-descriptionofsecuriti.htm | EX-4.3 | 7929
3 | EX-19.1 | fold-insidertradingpolicy_.htm | EX-19.1 | 137745
4 | EX-21 | exhibit21_2024.htm | EX-21 | 9372
5 | EX-23.1 | exhibit231_2024.htm | EX-23.1 | 11933
6 | EX-31.1 | exhibit311_2024.htm | EX-31.1 | 8317
7 | EX-31.2 | exhibit312_2024.htm | EX-31.2 | 8358
8 | EX-32.1 | exhibit321_2024.htm | EX-32.1 | 3219
9 | EX-32.2 | exhibit322_2024.htm | EX-32.2 | 3175
15 | GRAPHIC | fold-20241231_g1.jpg | GRAPHIC | 102412
| Complete submission text file | 0001178879-25-000003.txt |  | 9846897

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | fold-20241231.xsd | EX-101.SCH | 53452
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | fold-20241231_cal.xml | EX-101.CAL | 107131
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | fold-20241231_def.xml | EX-101.DEF | 207582
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | fold-20241231_lab.xml | EX-101.LAB | 782355
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | fold-20241231_pre.xml | EX-101.PRE | 529412
106 | EXTRACTED XBRL INSTANCE DOCUMENT | fold-20241231_htm.xml | XML | 1277912

Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33497 | Film No.: 25639808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)